화학정보학 시장 예측(-2030년) : 제품, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Cheminformatics Market is accounted for $3.4 billion in 2023 and is expected to reach $10.5 billion by 2030 growing at a CAGR of 17.5% during the forecast period. Chemoinformatics is the integration of computer and informational approaches to a variety of chemistry-related problems. Chemoinformatics is the blending of various information resources with the aim of converting data into knowledge and knowledge into information in order to make better decisions rapidly in the area of drug lead optimization. Pharmaceutical companies employ these methods when seeking for new drugs. These techniques can also be applied in a variety of other contexts in the chemical and related sectors.

According to the report published by Frontiers in Chemistry in April 2021, virtual screening strategies innovated the discovery of new bioactive molecules.

Market Dynamics:

Driver:

Increased drug development and discovery

The biotechnology and pharmaceutical sectors constantly strive to develop and market cutting-edge medications. Cheminformatics software and technologies are essential to this endeavor since they haveten the drug development process. With the assistance of these tools, researchers can quickly examine large data sets, model molecular interactions, and forecast the characteristics of possible drug candidates, greatly cutting down on the time and expense normally associated with trial-and-error methods. Additionally, cheminformatics helps chemists discover interesting medication candidates, comprehend the connections between the structure and activity of compounds, and improve the attributes of these molecules. As a result, the market for cheminformatics is expanding rapidly as businesses try to use these technologies to accelerate drug discovery, which will eventually result in the release of new drugs and therapies to deal with a variety of health issues.

Restraint:

High initial expenses

Implementing cheminformatics systems along with acquiring the required software, hardware, and knowledge can be expensive, especially for startups, academic institutions, and smaller research organizations with limited resources. For many potential users, the expense of licensing sophisticated cheminformatics software, purchasing potent computational resources, and training employees to utilize these tools effectively might operate as a barrier to entry. Additional ongoing costs for maintenance, updates, and support also add to the financial burden.

Opportunity:

Toxicology chemical informatics

Due to the vital role in ensuring the safety and efficacy of chemicals and pharmaceutical substances, chemical informatics for toxicology is a major driver of the cheminformatics market. Cheminformatics technologies are crucial for anticipating and assessing the potential toxicological effects of various chemical substances due to the growing demand for rigorous safety assessments and regulatory compliance. Moreover, with the aid of these technologies, scientists can model and simulate how chemicals interact with biological systems, assisting in the early identification of possible risks and their mitigation. This skill plays a crucial role in safeguarding public health as well as saving a significant amount of time and resources.

Threat:

Data security and privacy issues

Massive amounts of sensitive and confidential chemical and biological data, including details on prospective medicinal compounds, molecular structures, and research findings, are handled within this discipline. A top priority is to protect this data from unauthorized access, breaches, or theft, especially in the fiercely competitive chemical and pharmaceutical industries. However, these difficulties get worse due to legal restrictions, ethical considerations, and the need for researchers to follow strict data protection laws and address privacy and intellectual property issues. Data breaches or improper treatment can have serious repercussions, including legal consequences and reputational harm.

COVID-19 Impact:

The COVID-19 pandemic has had a wide range of effects on the market for cheminformatics. On the other hand, the need for rapid virus therapies and vaccinations pushed the use of cheminformatics techniques in drug development. These technologies were used by researchers to accelerate the medication development process and examine the molecular structure of the virus and its interactions with prospective therapeutic molecules. The need for chemical products and services increased as a result. The pandemic, however, caused difficulties for the cheminformatics sector. The general operations of the industry were impacted by supply chain disruptions, laboratory closures, and changes in research objectives.

The virtual screening segment is expected to be the largest during the forecast period

Virtual Screening segment hold the largest share over the projection period. Virtual screening is a method of computing that makes use of software and tools from the field of cheminformatics to forecast and examine the interactions between possible therapeutic molecules and certain biological targets, such as proteins or enzymes. It enables scientists to virtually evaluate a vast library of chemical compounds, reducing the number of potential therapeutic candidates for additional experimental testing. By minimizing the number of compounds that must be manufactured and analyzed in the lab, this method substantially speeds up the drug discovery pipeline while using less capital.

The software segment is expected to have the highest CAGR during the forecast period

Due to the wide variety of specialized software programs and tools developed to meet the requirements of researchers, chemists, and scientists in many sectors, the software segment is anticipated to have the highest CAGR throughout the projection period. Additionally, these software programs are made to handle and evaluate chemical and biological data, help with molecular modeling, forecast chemical properties, and speed up the creation of new drugs. Cheminformatics software includes tools for virtual screening, data visualization and analysis, chemical structure databases, and molecular modeling.

Region with largest share:

Due to growing financing in the biotechnology industry, North America held the majority of the market over the predicted period. It accelerates medication discovery, new platform releases and approvals, and the presence of numerous important firms in the area. For instance, Dotmatics introduced its small-molecule drug discovery service in the United States in July 2022. It is an integrated platform for scientific R&D that has expanded data management capabilities and workflows that are already set up. The Small Molecule Drug Discovery Solution minimizes operational inefficiencies, fosters increased research team efficiency, and hastens the conversion of data into insights and decisions.

Region with highest CAGR:

Asia Pacific is estimated to witness lucrative growth over the forecast period due to low manufacturing and labor costs and a supportive industrial environment, some developing economies in the Asia Pacific area, including India, China, and Singapore, have attracted major multinational firms to conduct research. Additionally, it is anticipated that the increasing rate of research activity in the rapidly developing countries of the Asia-Pacific area will support growth further.

Key players in the market

Some of the key players in Cheminformatics market include: Advanced Chemistry Development, Inc., Advent Informatics Pvt. Ltd., Agilent Technologies, Inc., Altoris, Bio-Rad Laboratories, Inc, BioSolveIT GmbH, Cambridgesoft Corp , Certara, Inc., ChemAxon Inc, Collaborative Drug Discovery Inc., Dassault Systems SE, Eidogen-Sertanty, Inc., Golden Helix, Inc., Kode Chemoinformatics, Modgraph Consultants Ltd., Molecular Discovery Ltd, Molinspiration Cheminformatics, Molsoft L.L.C, RTI International, Schrodinger, Inc. and Scilligence Corporation.

Key Developments:

In September 2022, Cadence Design Systems, Inc. completed the acquisition of OpenEye Scientific Software, Inc. Adding OpenEye's technologies and experienced team accelerates the Cadence Intelligent System Design strategy. It is done by extending Cadence's computational software core competency to molecular modeling and simulation targeted to life sciences.

In June 2022, TetraScience, the R&D Data Cloud, stated that ChemAxon, one of the leading web-based cheminformatics and bioinformatics software providers, joined the Tetra Partner Network. It is to help customers dramatically increase their capacity to find and synthesize chemical compounds with improved property profiles.

Products Covered:

• Services
• Software
• Other Products

Applications Covered:

• Chemical Analysis
• Virtual Screening
• Drug Discovery and Validation
• Other Applications

End Users Covered:

• Academic & Research Institutes
• Biotechnology Companies
• Contract Research Organizations
• Pharmaceutical Companies
• Regulatory Compliance
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Cheminformatics Market, By Product

• 5.1 Introduction
• 5.2 Services
• 5.3 Software
• 5.4 Other Products

6 Global Cheminformatics Market, By Application

• 6.1 Introduction
• 6.2 Chemical Analysis
  • 6.2.1 Chemometrics
  • 6.2.2 Chemical Databases
  • 6.2.3 Molecular Modelling
  • 6.2.4 Other Chemical Analysis
• 6.3 Virtual Screening
• 6.4 Drug Discovery and Validation
• 6.5 Other Applications

7 Global Cheminformatics Market, By End User

• 7.1 Introduction
• 7.2 Academic & Research Institutes
• 7.3 Biotechnology Companies
• 7.4 Contract Research Organizations
• 7.5 Pharmaceutical Companies
• 7.6 Regulatory Compliance
• 7.7 Other End Users

8 Global Cheminformatics Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Advanced Chemistry Development, Inc.
• 10.2 Advent Informatics Pvt. Ltd.
• 10.3 Agilent Technologies, Inc.
• 10.4 Altoris
• 10.5 Bio-Rad Laboratories, Inc
• 10.6 BioSolveIT GmbH
• 10.7 Cambridgesoft Corp
• 10.8 Certara, Inc.
• 10.9 ChemAxon Inc
• 10.10 Collaborative Drug Discovery Inc.
• 10.11 Dassault Systems SE
• 10.12 Eidogen-Sertanty, Inc.
• 10.13 Golden Helix, Inc.
• 10.14 Kode Chemoinformatics
• 10.15 Modgraph Consultants Ltd.
• 10.16 Molecular Discovery Ltd
• 10.17 Molinspiration Cheminformatics
• 10.18 Molsoft L.L.C
• 10.19 RTI International
• 10.20 Schrodinger, Inc.
• 10.21 Scilligence Corporation